New approaches for improving cardiovascular risk assessment

Simão Paredes1, Teresa Rocha1, Diana Mendes2

  • 1Polytechnic Institute of Coimbra (IPC/ISEC), Computer Science and Systems Engineering Department, Rua Pedro Nunes, 3030-199 Coimbra, Portugal; CISUC, Center for Informatics and Systems of University of Coimbra, University of Coimbra, Pólo II, 3030-290 Coimbra, Portugal.

Insights

This study introduces a new framework to improve cardiovascular risk assessment tools, enhancing their reliability for better clinical decision-making in predicting cardiovascular death. The novel approach shows promising results in initial patient data analysis.

Area of Science:

  • Cardiology
  • Medical Informatics

Background:

  • Clinical guidelines advocate for cardiovascular risk assessment tools (risk scores) to predict cardiovascular death and aid decision-making.
  • Current risk scores have limitations impacting their reliability in clinical settings.
  • Cardiovascular disease (CVD) poses significant social and economic burdens.

Purpose of the Study:

  • To present a novel framework designed to enhance existing cardiovascular risk assessment tools.
  • To minimize the limitations of current risk scores and improve their clinical reliability.
  • To aid in more accurate prediction of cardiovascular events.

Main Methods:

  • Developed a framework combining data from multiple sources, including existing risk scores and physician input.
  • Implemented a personalization scheme to group patients and identify the most suitable risk assessment tool for individual cases.
  • Applied two distinct methodologies for data processing and patient stratification.

Main Results:

  • Validation performed on a dataset of 460 patients with non-ST-segment elevation acute coronary syndrome.
  • The proposed approaches demonstrated promising performance metrics, including sensitivity, specificity, and geometric mean.
  • Specific performance metrics achieved were 78.79% sensitivity, 73.07% specificity, and 75.87% geometric mean for one approach, and 75.69%, 69.79%, and 72.71% for the other.

Conclusions:

  • The developed approaches show superior performance compared to current cardiovascular disease risk scores.
  • Further validation with additional datasets is recommended to substantiate these findings.
  • The framework offers a potential improvement in predicting cardiovascular risk.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
578
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
839
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
792